Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Personalized medicine – or matching a patient’s tumor with an appropriate treatment – is transforming lung cancer and bringing a measure of hope to patients, according to a review by Eric S. Kim, M.D., and Kishan J. Pandya, M.D., of the James P. Wilmot Cancer Center, published in the journal Expert Opinion on Medical Diagnostics.
8/15/2013 | 1 comment
Matt Kottmann, M.D., assistant professor in the division of Pulmonary and Critical Care Medicine, received a highly competitive Parker B. Francis Fellowship grant to study lung scarring. Kottmann is one of just 11 lung researchers in the U.S. to receive the award.
6/24/2013 | 0 comments